MedPath

Mobile Apps for the Treatment of Depression

Not Applicable
Withdrawn
Conditions
Major Depressive Disorder
Registration Number
NCT02024620
Lead Sponsor
Central Arkansas Veterans Healthcare System
Brief Summary

Smartphone applications (apps) may be well-suited as a low cost adjunctive tool for increasing the adherence of individuals to psychotherapy treatments which may subsequently increase symptom reduction and improve clinical outcomes. Apps offer the opportunity for real-time tracking of behavior and have the ability to provide prompt feedback and reminders in a convenient, readily available technology. The immediacy and convenience of apps may be responsible for the observed improvements in adherence on the part of the patients relative to traditional paper-and-pencil tracking and practice of skills taught in psychotherapy. These features are relevant to behavioral activation (BA) protocols, the effects of which are often attenuated by failure to adhere to regular practice and tracking of behavior. The Mood Coach app is a BA protocol developed to provide a convenient means of planning and tracking activity, and monitoring mood responses to scheduled increases in activity. This project evaluates the utility of this app as an adjunct to standard BA treatment. The investigators predict that participants assigned to the BA+app condition will demonstrate greater adherence to the BA treatment compared to the standard BA condition. The investigators also predict that the participants in the BA+app condition will report greater satisfaction with the app compared to the standard BA protocol that utilizes paper and pencil materials.

Detailed Description

Not available

Recruitment & Eligibility

Status
WITHDRAWN
Sex
All
Target Recruitment
Not specified
Inclusion Criteria
  • Veterans aged 18 and older
  • Speak and understand English
  • Meet criteria for major depressive disorder
  • Willing to participate in psychotherapy for depression
Exclusion Criteria
  • Current psychotic disorder diagnosis
  • Current bipolar disorder
  • Diagnosed with a substance use disorder that is not currently being addressed by a non-study provider
  • Patients receiving a concurrent evidence-based psychotherapy for depression or PTSD

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Change in Behavioral Activation for Depression Scale-Short FormWeek 1, Week 4, Week 8

Measures symptoms of depression consistent with a behavioral deficits model in a brief format.

Secondary Outcome Measures
NameTimeMethod
Change in Depression Anxiety Stress Scales-21Week 1, Week 4, Week 8

Assesses symptoms of depression, anxiety, and stress in a brief format.

Trial Locations

Locations (1)

Central Arkansas Veterans Healthcare System

πŸ‡ΊπŸ‡Έ

North Little Rock, Arkansas, United States

Central Arkansas Veterans Healthcare System
πŸ‡ΊπŸ‡ΈNorth Little Rock, Arkansas, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Β© 2025 MedPath, Inc. All rights reserved.